Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Oct 22, 2010

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genome Canada has appointed Pierre Meulian to be president and CEO, a job he assumed earlier this week. Meulien, who replaces interim President and CEO Dale Patterson, is stepping down from his post as chief scientific officer of Genome BC to take on the new position. Patterson will continue his work in the role of VP of Genome Canada's external relations.

For more on Meulian's plans for Genome Canada, please see today's article in GenomeWeb Daily News.

CombiMatrix has appointed Daniel Forche to be senior VP of sales and marketing. Forche comes to CombiMatrix from Agendia, where he held the same title as his new post, and before that he worked in marketing and sales at Ventana Medical Systems and at Abbott Laboratories' Diagnostics Division.

Paul Miller, a law professor at the University of Washington, an advisor to two White Houses, and a champion for rights for the disabled and for legal protections against genetic discrimination, died this week at age 49.

Miller served as a member of the Secretary's Advisory Committee on Genetics, Health, and Society as it worked on issues such as genetic testing ethics and regulations and genetic discrimination.

Miller served as an adviser and a liaison on disability issues and a range of other matters for the administrations of Presidents Bill Clinton and Barack Obama, and he served on the US Equal Employment Opportunity Commission.

Susan Lindquist, a researcher at the Whitehead Institute for Biomedical Research, was named a winner of the National Medal of Science by US President Barack Obama.

Lindquist, who also is a professor at the Massachusetts Institute of Technology and a Howard Hughes Medical Institute investigator, was cited for her studies on protein folding, and the demonstration that alternative protein conformations and aggregations can provide information about disease, evolution, and biology.

Lindquist is expected to receive the medal at a White House ceremony next month.

Wilbert Keon has retired from his position as a director at Med BioGene, where he has served since 2004. Keon was a professor and chair of the University of Ottawa Department of Surgery for 15 years.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.